Continuous Glucose Monitoring Market Gains Momentum, Attracts Focus on Preventive Care | Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics s.r.l

"Global Continuous Glucose Monitoring by DataM Intelligence estimates the market to grow at a CAGR of 22% during the forecast period 2024-2031." As per DataM intelligence research report

Market growth opportunities(2025-2031):

The CGM market is projected to grow robustly through 2031, driven by rising diabetes prevalence and broader adoption of home-based glucose monitoring devices. Advancements in sensor miniaturization, longer wear durations, and real-time data connectivity are reshaping device usability and expanding application. Over-the-counter CGM availability is opening avenues in wellness and metabolic tracking beyond clinical diabetes management. Integration with remote monitoring platforms and subscription-based analytical services is generating recurring revenue streams. Emerging and low- to middle-income regions represent high-growth frontiers as healthcare access improves.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/continuous-glucose-monitoring-market?sp

Continuous Glucose Monitoring Market: Recent Industry Developments

✅In July 2025 Researchers from MNNIT Prayagraj and RMLIMS, Lucknow, unveiled a patented, real-time non-invasive glucose sensor that uses electromagnetic waves between thumb and index finger to measure blood sugar-no finger pricks needed, and projected retail price under ₹500 (~USD 6 7).

✅In April 2025 The FDA granted clearance for the G7 15 Day sensor, extending continuous wear up to 15.5 days (including a 12-hour grace period). It's slightly more accurate (MARD ~8.0 %) than the original G7 (~8.2 %) and supports integration with systems like Tandem's t:slim X2, Insulet Omnipod 5, and Beta Bionics iLet. U.S. availability is anticipated in H2 2025.

Continuous Glucose Monitoring Market: Market Drivers

The growing global burden of type 1 and type 2 diabetes is accelerating demand for continuous glucose monitoring solutions. Sensor innovations including longer-lasting and more accurate models like Dexcom G7 and Abbott Libre series are enhancing clinical appeal. Expanded reimbursement policies, including coverage for non-insulin-dependent type 2 patients and OTC access, are boosting adoption rates. Increasing integration with telehealth and digital health platforms enables remote patient monitoring and personalized care models. Consumer wellness applications driven by fitness and metabolic health tracking-are also fueling market enthusiasm.

Strategic Players Driving the Continuous Glucose Monitoring Market Forward:

✦ Abbott Laboratories
✦ Dexcom, Inc.
✦ A. Menarini Diagnostics s.r.l
✦ Echo Therapeutics, Inc.
✦ GlySens Incorporated
✦ Johnson and Johnson
✦ Medtronic Plc
✦ Senseonics Holdings, Inc.
✦ F. Hoffmann-La Roche Ltd
✦ Medtrum Technologies, Inc.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/continuous-glucose-monitoring-market?sp

Segment Covered in the Continuous Glucose Monitoring Market:

➥By Component: Transmitter, Receiver, Sensor, Insulin Pumps, Others

➥By End User: Diagnostic Centers, ICUs, Home Healthcare

Why Purchase the Report for Continuous Glucose Monitoring Market?:

➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.

Regional Analysis for Continuous Glucose Monitoring Market:

North America leads the market, accounting for a significant portion of global revenues, supported by strong reimbursement systems, high diabetes prevalence, and widespread device adoption. Europe holds the second-largest share, underpinned by well-funded healthcare systems and structured diabetes care frameworks. Asia-Pacific is the fastest-growing region, with high unmet needs, rising awareness, expanding healthcare infrastructure, and smartphone penetration enabling broader CGM uptake.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=continuous-glucose-monitoring-market?sp

Conclusion:

The CGM market is positioned for strong expansion through 2031, propelled by rising diabetes rates, sensor innovations, and broader reimbursement and OTC product access. Technological progress-in longer-duration wear sensors, non-invasive sensing, and AI-powered analytics-is enhancing patient usability and expanding the user base. North America and Europe remain dominant in value, while Asia-Pacific emerges as the fastest-maturing market opportunity. Staying competitive will require focus on hybrid connectivity, seamless healthcare integration, and tailored offerings that address regional affordability and adoption barriers.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.